Fanconi anemia - learning from children
- PMID: 22053284
- PMCID: PMC3206526
- DOI: 10.4081/pr.2011.s2.e8
Fanconi anemia - learning from children
Abstract
Fanconi Anemia (FA) is a rare autosomic recessive and X-linked disease with chromosomal instability after exposure to crosslinking agents as the hallmark. Clinical features of FA are somatic malformations, progressive bone marrow failure and cancer proneness, however there is wide clinical heterogeneity. The symptom most frequently and early associated with morbidity and mortality is progressive pancytopenia in the first decade of life although acute myelogenous leukemia (AML) or myelodysplastic syndrome (MDS) can appear before aplastic anemia. Squamous cell carcinoma (SCC) of the head-neck, intestinal or genital tract has a very high incidence in FA and can appear at young age. This paper will focus on treatment of bone marrow failure in FA.
Keywords: Fanconi anemia..
References
-
- Alter BP. Nathan and Oski's Hematology of Infancy and Childhood. In: Nathan D.G, et al., editors. Inherited Bone Marrow Failure Syndromes: Fanconi Anemia. 6th edition. Philadelphia: Saunders; 2003. pp. 281–299.
-
- Callen E, Casado JA, Tischkowitz MD, et al. A common founder mutation in FANCA underlies the world's highest prevalence of Fanconi anemia in Gypsy families from Spain. Blood. 2005;105:1946–9. - PubMed
-
- Mehta PA, Harris RE, Davies SM, et al. Numerical chromosomal changes and risk of development of myelodysplastic syndrome-acute myeloid leukemia in patients with Fanconi anemia. Cancer Genet Cytogenet. 2010;203:180–6. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
